Purchase Order 75D30124P18767
Award Date 8/19/24
Potential Completion Date 10/16/26
Potential Value $94K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Fort Collins, CO 80521, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and software. The contract is for the purchase of a MiSeq System, a benchtop DNA sequencing platform, for $95,931. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received other federal prime and subcontract awards from agencies like the National Institutes of Health (NIH),...
- This federal contract award to Illumina, Inc., a biotechnology company specializing in genetic sequencing and genomic analysis technologies, was issued by the Centers for Disease Control and Prevention (CDC) for a MiSeq Silver Plan asset. The $176,416.32 firm fixed-price purchase order has an ultimate completion date of July 20, 2029. Illumina has been awarded multiple federal contracts and Indefinite Delivery Vehicles (IDVs) from agencies such as the U.S. Department of Agriculture (USDA) and...
- This federal contract award to Illumina, Inc. is for the purchase of a NEXTSEQ 1000 SEQ SYSTEM, a genetic sequencing instrument, by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, PA. The $159,600.00 firm fixed-price purchase order does not have a set-aside designation. Illumina is a manufacturer and provider of genetic and genomic analysis instruments and reagents, and has received previous prime contract awards from federal agencies like the NIH, USDA, and VA to support...
- This federal contract award, valued at $142,053.98, was made by the Centers for Disease Control and Prevention (CDC) Pittsburgh to Illumina, Inc., a manufacturer of genomic sequencing equipment and reagents. The contract is for the provision of laboratory equipment, specifically various Illumina sequencing systems including NextSeq, NovaSeq, MiSeq, and iSeq, as well as associated consumables, sample preparation kits, and bioinformatics products. Illumina has previously been awarded other federal...
- This $96,401.25 firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh facility to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis products. The contract is for the provision of a MiSeq DNA sequencing system and does not have a set-aside designation. Illumina has previously received prime federal contract awards from agencies like the NIH, USDA, VA, and others for sequencing systems, reagents, and...
- This federal contract award is for the purchase of laboratory equipment from Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $140,700.00, was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian agency. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contracts and subcontracts from various...
- This federal contract award was issued by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $47,901.74 firm fixed price purchase order is for the provision of MiSeq Reagent Kit V2, which supports the company's MiSeq sequencing platform. This award does not utilize any set-aside designations. Through past prime and subcontract awards from agencies such as the National Institutes of...
- This firm fixed-price contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Illumina, Inc., a manufacturer of genetic analysis instruments and reagents. The $158,939.56 award is for the provision of Illumina's MiSeq sequencing platform and related consumables to support comprehensive genomic analysis work. This contract is not set aside for any small business categories. Illumina has previously received prime contract awards from...
- This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing equipment and reagents. The contract is for the provision of a MiSeq sequencing system, valued at $97,020.00. The contract has an ultimate completion date of October 19, 2020. Illumina has previously been awarded federal contracts and grants by agencies such as the National Institutes of Health, USDA, and VA to provide a range of sequencing...
- This is a firm-fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic sequencing instruments and related products. The contract is for the provision of an Illumina MiSeq instrument system, valued at $96,401.25, with an ultimate completion date of August 30, 2017. Illumina has previously received prime federal contracts and subcontracts from various agencies, such as the National Institutes of Health, USDA, and...